$3.57
0.97%
NYSE, Sep 25, 04:04 pm EDT. Closed.
ISIN
US58463J3041
Symbol
MPT

Medical Properties Trust Target price 2026 - Analyst rating & recommendation

Medical Properties Trust Classifications & Recommendation

Buy
19%
Hold
31%
Sell
50%

Medical Properties Trust Price Target

Target Price $5.10
Price $3.57
Potential
Number of Estimates 8
8 Analysts have issued a price target Medical Properties Trust 2027 . The average Medical Properties Trust target price is $5.10. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 3 Analysts recommend Medical Properties Trust to buy, 5 to hold and 8 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medical Properties Trust stock has an average upside potential 2027 of . Most analysts recommend the Medical Properties Trust stock at Sale.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 0.97 1.03
2.36% 6.27%
EBITDA Margin 82.84% 82.12%
1.18% 0.86%
Net Margin -28.59% 5.25%
88.19% 118.36%

8 Analysts have issued a sales forecast Medical Properties Trust 2026 . The average Medical Properties Trust sales estimate is

$1.0b
unlock
. This is
1.35% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.1b 7.44%
unlock
, the lowest is
$955m 6.28%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $972m 2.36%
2026
$1.0b 6.27%
unlock
2027
$1.1b 3.48%
unlock
2028
$1.1b 1.31%
unlock
2029
$1.1b 5.31%
unlock
2030
$1.1b 3.06%
unlock

9 Analysts have issued an Medical Properties Trust EBITDA forecast 2026. The average Medical Properties Trust EBITDA estimate is

$848m
unlock
. This is
0.23% lower
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$953m 12.08%
unlock
, the lowest is
$783m 7.90%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $805m 3.51%
2026
$848m 5.36%
unlock
2027
$876m 3.27%
unlock
2028
$872m 0.51%
unlock
2029
$909m 4.29%
unlock
2030
$936m 3.00%
unlock

EBITDA Margin

2025 82.84% 1.18%
2026
82.12% 0.86%
unlock
2027
81.95% 0.21%
unlock
2028
82.62% 0.82%
unlock
2029
81.82% 0.97%
unlock
2030
81.77% 0.06%
unlock

7 Medical Properties Trust Analysts have issued a net profit forecast 2026. The average Medical Properties Trust net profit estimate is

$54.3m
unlock
. This is
271.68% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$68.9m 318.13%
unlock
, the lowest is
$35.1m 211.04%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-278m 88.47%
2026
$54.3m 119.52%
unlock
2027
$54.3m 0.00%
unlock

Net Margin

2025 -28.59% 88.19%
2026
5.25% 118.36%
unlock
2027
5.07% 3.43%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.46 0.09
88.56% 119.57%
P/E 39.27
EV/Sales 11.08

7 Analysts have issued a Medical Properties Trust forecast for earnings per share. The average Medical Properties Trust EPS is

$0.09
unlock
. This is
280.00% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$0.12 340.00%
unlock
, the lowest is
$0.06 220.00%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.46 88.56%
2026
$0.09 119.57%
unlock
2027
$0.09 0.00%
unlock

P/E ratio

Current -71.40 3,291.92%
2026
39.27 155.00%
unlock
2027
39.27 0.00%
unlock

Based on analysts' sales estimates for 2026, the Medical Properties Trust stock is valued at an EV/Sales of

11.08
unlock
and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.22 15.00%
2026
11.08 1.29%
unlock
2027
10.70 3.37%
unlock
2028
10.84 1.33%
unlock
2029
10.30 5.04%
unlock
2030
9.99 2.97%
unlock

P/S ratio

Current 2.09 36.35%
2026
2.06 1.33%
unlock
2027
1.99 3.37%
unlock
2028
2.02 1.33%
unlock
2029
1.92 5.04%
unlock
2030
1.86 2.97%
unlock

Current Medical Properties Trust Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
➜
Locked
Locked Sep 01 2026
RBC Capital
Locked
➜
Locked
Locked Jun 18 2026
RBC Capital
Locked
➜
Locked
Locked Mar 02 2026
Wells Fargo
Locked
➜
Locked
Locked Nov 25 2025
Wells Fargo
Locked
➜
Locked
Locked Aug 27 2025
RBC Capital
Locked
➜
Locked
Locked Jun 30 2025
Exane BNP Paribas
Locked
➜
Locked
Locked Mar 12 2025
Analyst Rating Date
Locked
Wells Fargo:
Locked
➜
Locked
Sep 01 2026
Locked
RBC Capital:
Locked
➜
Locked
Jun 18 2026
Locked
RBC Capital:
Locked
➜
Locked
Mar 02 2026
Locked
Wells Fargo:
Locked
➜
Locked
Nov 25 2025
Locked
Wells Fargo:
Locked
➜
Locked
Aug 27 2025
Locked
RBC Capital:
Locked
➜
Locked
Jun 30 2025
Locked
Exane BNP Paribas:
Locked
➜
Locked
Mar 12 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today